ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q907. A total of 6 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $416,000 | -49.3% | 11,100 | -8.3% | 0.00% | -50.0% |
| Q3 2016 | $820,000 | +150.8% | 12,100 | +105.1% | 0.00% | +100.0% |
| Q2 2016 | $327,000 | -82.3% | 5,900 | -80.0% | 0.00% | -77.8% |
| Q1 2016 | $1,852,000 | +155.4% | 29,500 | +283.1% | 0.01% | +125.0% |
| Q4 2015 | $725,000 | -74.1% | 7,700 | -77.9% | 0.00% | -66.7% |
| Q3 2015 | $2,797,000 | +156.4% | 34,800 | +282.4% | 0.01% | +140.0% |
| Q2 2015 | $1,091,000 | +422.0% | 9,100 | +355.0% | 0.01% | +400.0% |
| Q1 2015 | $209,000 | -56.9% | 2,000 | -60.0% | 0.00% | -50.0% |
| Q4 2014 | $485,000 | +1.0% | 5,000 | -34.2% | 0.00% | 0.0% |
| Q2 2014 | $480,000 | -62.6% | 7,600 | -60.2% | 0.00% | -60.0% |
| Q1 2014 | $1,282,000 | +197.4% | 19,100 | +37.4% | 0.01% | +150.0% |
| Q2 2013 | $431,000 | – | 13,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 75,000 | $6,027,000 | 2.71% |
| SABBY MANAGEMENT, LLC | 1,676 | $13,468,000 | 0.56% |
| Timber Hill LLC | 34,800 | $2,797,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 9,800 | $788,000 | 0.01% |
| Citadel Advisors | 53,600 | $4,307,000 | 0.00% |
| SIMPLEX TRADING, LLC | 176 | $23,000 | 0.00% |